Arjuna Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.5M | Sell |
117,161
-6,169
| -5% | -$237K | 1.19% | 19 |
|
|
2025
Q1 | $4.78M | Sell |
123,330
-41,736
| -25% | -$1.62M | 1.32% | 17 |
|
|
2024
Q4 | $5.58M | Buy |
165,066
+86,132
| +109% | +$2.91M | 1.49% | 17 |
|
|
2024
Q3 | $3.23M | Buy |
78,934
+46,621
| +144% | +$1.91M | 0.84% | 42 |
|
|
2024
Q2 | $1.24M | Buy |
32,313
+235
| +0.7% | +$9.05K | 0.33% | 71 |
|
|
2024
Q1 | $1.38M | Buy |
32,078
+825
| +3% | +$35.4K | 0.39% | 69 |
|
|
2023
Q4 | $1.16M | Buy |
+31,253
| New | +$1.16M | 0.36% | 72 |
|
|
2022
Q3 | – | Sell |
-26,069
| Closed | -$1.42M | – | 96 |
|
|
2022
Q2 | $1.42M | Buy |
26,069
+700
| +3% | +$38.1K | 0.69% | 39 |
|
|
2022
Q1 | $1.38M | Buy |
25,369
+5,559
| +28% | +$303K | 0.58% | 48 |
|
|
2021
Q4 | $1.09M | Buy |
+19,810
| New | +$1.09M | 0.4% | 62 |
|
|
2020
Q3 | – | Sell |
-14,695
| Closed | -$749K | – | 92 |
|
|
2020
Q2 | $749K | Buy |
14,695
+185
| +1% | +$9.43K | 0.52% | 54 |
|
|
2020
Q1 | $687K | Buy |
+14,510
| New | +$687K | 0.57% | 50 |
|
|
2019
Q2 | – | Sell |
-3,950
| Closed | -$206K | – | 98 |
|
|
2019
Q1 | $206K | Sell |
3,950
-22,155
| -85% | -$1.16M | 0.16% | 90 |
|
|
2018
Q4 | $1.25M | Sell |
26,105
-247
| -0.9% | -$11.8K | 1.14% | 32 |
|
|
2018
Q3 | $1.32M | Buy |
26,352
+338
| +1% | +$17K | 1% | 37 |
|
|
2018
Q2 | $1.31M | Sell |
26,014
-5
| -0% | -$252 | 1.07% | 38 |
|
|
2018
Q1 | $1.27M | Buy |
26,019
+1,085
| +4% | +$53K | 1.07% | 38 |
|
|
2017
Q4 | $1.11M | Buy |
+24,934
| New | +$1.11M | 1.03% | 36 |
|